Eric D. Achtyes, MD, MS

A consensus panel reviews the pharmacokinetic advantages and clinical utility of long-acting injectable aripiprazole monohydrate to optimize treatment for schizophrenia and bipolar I disorder.

Primary care has become the de facto mental health care system for many patients, yet primary care provider (PCP) comfort level in treating mental disorders is largely unknown. This...